FIGS (NYSE:FIGS) Issues Earnings Results

FIGS (NYSE:FIGSGet Free Report) released its quarterly earnings results on Thursday. The company reported $0.10 EPS for the quarter, topping analysts’ consensus estimates of $0.02 by $0.08, FiscalAI reports. FIGS had a return on equity of 4.50% and a net margin of 3.03%.The company had revenue of $201.90 million for the quarter, compared to analysts’ expectations of $165.33 million. During the same period in the prior year, the firm earned $0.01 earnings per share. The firm’s revenue was up 33.0% compared to the same quarter last year.

Here are the key takeaways from FIGS’s conference call:

  • Q4 net revenue surged 33% year-over-year to $201.9 million with active customers rising to a record 2.9 million, +9% YoY, and AOV up 9%, driving strong profitability in the quarter.
  • Full-year 2025 milestones included record net revenue of $631.1 million, scrub wear crossing the $500 million mark, international sales topping $100 million, and a record net cash/investment position of $300.8 million.
  • Gross margin faced headwinds from tariff pressures and a deliberate $5.6 million inventory write-off in Q4, and management assumes a 15% global tariff that would add ~280 basis points of drag in 2026.
  • Management guided fiscal 2026 to net revenue growth of 10–12% with improved profitability targets — adjusted EBITDA margin of 12.7–12.9% and operating margin of 7.6–7.9% — while planning continued investments and opportunistic buybacks.
  • Expansion initiatives showed momentum: international net revenue grew 55% in Q4 with new market entries (e.g., China, South Korea) and plans to exceed 80 markets, plus category and channel builds (Teams B2B, community hubs, product fabric innovations) to broaden future growth.

FIGS Trading Up 15.0%

NYSE:FIGS traded up $1.64 during mid-day trading on Thursday, hitting $12.60. The stock had a trading volume of 9,780,949 shares, compared to its average volume of 2,828,274. FIGS has a twelve month low of $3.57 and a twelve month high of $12.66. The stock has a 50-day simple moving average of $11.33 and a two-hundred day simple moving average of $9.29. The company has a market capitalization of $2.07 billion, a PE ratio of 126.00 and a beta of 1.29.

Analyst Ratings Changes

Several equities analysts have weighed in on FIGS shares. Telsey Advisory Group reaffirmed a “market perform” rating and issued a $9.00 target price on shares of FIGS in a research report on Friday, February 20th. Weiss Ratings reissued a “hold (c-)” rating on shares of FIGS in a research note on Monday, December 29th. BTIG Research upped their target price on shares of FIGS from $12.00 to $15.00 and gave the stock a “buy” rating in a research note on Wednesday, December 10th. Wall Street Zen lowered shares of FIGS from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Finally, Morgan Stanley raised their price target on shares of FIGS from $7.50 to $8.00 and gave the company an “equal weight” rating in a research report on Tuesday, January 13th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $10.10.

Check Out Our Latest Report on FIGS

Key Headlines Impacting FIGS

Here are the key news stories impacting FIGS this week:

  • Positive Sentiment: Q4 beat — FIGS reported EPS of $0.10 (vs. consensus $0.02) and revenue of $201.9M (vs. consensus $165.3M), showing clear top- and bottom-line outperformance that drove investor optimism. Press Release
  • Positive Sentiment: Raised FY2026 revenue guidance — management set revenue guidance of $694.2M–$706.8M, well above the street consensus (~$625.6M), signaling stronger growth expectations for the year and supporting a re-rating of the stock. FIGS Releases Fourth Quarter and Full Year 2025 Financial Results
  • Neutral Sentiment: Positive partnership momentum but uncertain lift — the company’s recent promotional push (including an Olympic-related partnership discussed in previews) may drive brand awareness and sales, but the near-term revenue impact is not quantified. Figs on deck with Q4 earnings after Olympic partnership push
  • Neutral Sentiment: Street stance remains cautious — analysts’ average rating is around “Hold,” suggesting investors should expect continued scrutiny even after the beat and guide. FIGS, Inc. Receives Average Recommendation of “Hold”
  • Negative Sentiment: Profitability and valuation risks — despite revenue strength, net margin remained low (~3.0%) and ROE modest (~4.5%), and the shares trade at a high P/E (~126x), leaving the stock sensitive to any margin pressure or growth shortfall. Press Release

Insiders Place Their Bets

In other FIGS news, insider Heather L. Hasson sold 22,874 shares of the firm’s stock in a transaction on Thursday, February 5th. The stock was sold at an average price of $10.56, for a total value of $241,549.44. Following the sale, the insider directly owned 1,251,967 shares in the company, valued at $13,220,771.52. This trade represents a 1.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Catherine Eva Spear sold 49,734 shares of FIGS stock in a transaction dated Tuesday, January 6th. The stock was sold at an average price of $11.38, for a total value of $565,972.92. Following the sale, the chief executive officer directly owned 1,857,299 shares of the company’s stock, valued at $21,136,062.62. This trade represents a 2.61% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold 105,813 shares of company stock worth $1,168,051 in the last 90 days. Corporate insiders own 29.44% of the company’s stock.

Hedge Funds Weigh In On FIGS

Several hedge funds have recently made changes to their positions in the company. Corient Private Wealth LLC grew its position in FIGS by 0.8% in the 2nd quarter. Corient Private Wealth LLC now owns 332,938 shares of the company’s stock valued at $1,878,000 after buying an additional 2,612 shares during the last quarter. Creative Planning boosted its holdings in shares of FIGS by 4.9% in the third quarter. Creative Planning now owns 68,932 shares of the company’s stock valued at $461,000 after acquiring an additional 3,192 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of FIGS by 4.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,219 shares of the company’s stock valued at $354,000 after acquiring an additional 3,276 shares in the last quarter. Swiss National Bank increased its stake in shares of FIGS by 2.2% during the fourth quarter. Swiss National Bank now owns 183,300 shares of the company’s stock worth $2,082,000 after acquiring an additional 3,900 shares during the period. Finally, Price T Rowe Associates Inc. MD raised its holdings in FIGS by 5.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 70,113 shares of the company’s stock worth $797,000 after purchasing an additional 3,918 shares in the last quarter. Hedge funds and other institutional investors own 92.21% of the company’s stock.

FIGS Company Profile

(Get Free Report)

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.

See Also

Earnings History for FIGS (NYSE:FIGS)

Receive News & Ratings for FIGS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for FIGS and related companies with MarketBeat.com's FREE daily email newsletter.